Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-013552
Filing Date
2015-10-02
Accepted
2015-10-02 08:27:06
Documents
1
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3335
  Complete submission text file 0001179110-15-013552.txt   4700
Mailing Address C/O ACORDA THERAPEUTICS, INC. 15 SKYLINE DRIVE HAWTHORNE NY 10532
Business Address
FISHER MARY (Reporting) CIK: 0001272360 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 151138491

Mailing Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142 617-500-2802
OvaScience, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations